Evidence map›Paper›PMID 35287700›Full record

ArticleSkeletal muscle2022

Functional replacement of myostatin with GDF-11 in the germline of mice.

Se-Jin Lee, Adam Lehar, Renata Rydzik, Daniel W Youngstrom, Shalender Bhasin, Yewei Liu, Emily L Germain-Lee

Open access · goldAbstract read
In one paragraph

Article in Skeletal muscle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. GDF11 and aging biology - controversies resolved and pending.The journal of cardiovascular aging · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Se-Jin LeeThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Se-Jin.Lee@jax.org.
Adam LeharThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Renata RydzikDepartment of Orthopaedic Surgery, University of Connecticut School of Medicine, Farmington, CT, USA.
Daniel W YoungstromDepartment of Orthopaedic Surgery, University of Connecticut School of Medicine, Farmington, CT, USA.
Shalender BhasinBrigham Research Assay Core Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Yewei LiuThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Emily L Germain-LeeDepartment of Pediatrics, University of Connecticut School of Medicine, Farmington, CT, USA.
University of Connecticut · USJackson Laboratory · USBrigham and Women's Hospital · USConnecticut Children's Medical Center · US

Funding

Characterization of Myostatin and GDF-11R01AR060636 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LEE, SE-JIN · 2010 to 2020
$3.7M
TGF-beta family members and their binding proteins in aging skeletal muscleR01AG052962 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LEE, SE-JIN, RANDO, THOMAS A. · 2017 to 2020
$1.9M
Anti-Geronic Factors, GDF11 and Oxytocin, and Aging-Related PhenotypesR56AG052972 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI BHASIN, SHALENDER · 2016 to 2017
$353k
NIAMS NIH HHS R01 AR060636NIA NIH HHS R01 AG052962NIA NIH HHS R56 AG052972
6 · The paper itself

Abstract

backgroundMyostatin (MSTN) is a transforming growth factor-ß superfamily member that acts as a major regulator of skeletal muscle mass. GDF-11, which is highly related to MSTN, plays multiple roles during embryonic development, including regulating development of the axial skeleton, kidneys, nervous system, and pancreas. As MSTN and GDF-11 share a high degree of amino acid sequence identity, behave virtually identically in cell culture assays, and utilize similar regulatory and signaling components, a critical question is whether their distinct biological functions result from inherent differences in their abilities to interact with specific regulatory and signaling components or whether their distinct biological functions mainly reflect their differing temporal and spatial patterns of expression.

methodsWe generated and characterized mice in which we precisely replaced in the germline the portion of the Mstn gene encoding the mature C-terminal peptide with the corresponding region of Gdf11.

resultsIn mice homozygous for the knock-in allele, all of the circulating MSTN protein was replaced with GDF-11, resulting in ~ 30-40-fold increased levels of circulating GDF-11. Male mice homozygous for the knock-in allele had slightly decreased muscle weights, slightly increased weight gain in response to a high-fat diet, slightly increased plasma cholesterol and HDL levels, and significantly decreased bone density and bone mass, whereas female mice were mostly unaffected.

conclusionsGDF-11 appears to be capable of nearly completely functionally replacing MSTN in the control of muscle mass. The developmental and physiological consequences of replacing MSTN with GDF-11 are strikingly limited.

Indexed as

Muscle, SkeletalMyostatinAmino Acid SequenceAnimalsBone Morphogenetic ProteinsFemaleGerm CellsGrowth Differentiation FactorsMaleMiceSignal TransductionBone Morphogenetic ProteinsGdf11 protein, mouseGrowth Differentiation FactorsMyostatinBody compositionBoneFatGDF-11Gene knock-inMetabolismMuscleMyostatin

Identifiers

PMID35287700
PMCPMC8922734
OpenAlexW4220953034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.